Indolactam and Benzolactam Compounds as New Medicinal Leads with Binding Selectivity for C1 Domains of Protein Kinase C Isozymes

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|10|12|1371-1385

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.10, Iss.12, 2004-05, pp. : 1371-1385

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Protein Kinase C Isozymes: Memory Therapeutic Potential

By  

Current Drug Targets-CNS & Neurological Disorders, Vol. 4, Iss. 5, 2005-10 ,pp. : 541-552

Bentham Science Publishers

Access to resources Recommend Favorite

Protein kinase C isozymes as potential therapeutic targets in immune disorders

By Lee Matthew R   Duan Wei   Tan Seng-Lai  

Expert Opinion on Therapeutic Targets, Vol. 12, Iss. 5, 2008-05 ,pp. : 535-552

Informa Healthcare

Access to resources Recommend Favorite

Pharmacologic Modulation of Protein Kinase C Isozymes: The Role of Racks and Subcellular Localisation

By Csukai M.   Mochly-Rosen D.  

Pharmacological Research, Vol. 39, Iss. 4, 1999-04 ,pp. : 253-259

Academic Press

Access to resources Recommend Favorite

Protein Kinase C Isozymes, Novel Phorbol Ester Receptors and Cancer Chemotherapy

By  

Current Pharmaceutical Design, Vol. 7, Iss. 17, 2001-11 ,pp. : 1725-1744

Bentham Science Publishers

Access to resources Recommend Favorite

Protein Kinase C Isozymes as Potential Targets for Anticancer Therapy

By  

Current Cancer Drug Targets, Vol. 4, Iss. 2, 2004-03 ,pp. : 125-146

Bentham Science Publishers

Access to resources Recommend Favorite